Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Laxmi Organic Industries LtdQ1 FY27Chemicals & Petrochemicals
Home/Stocks/Laxmi Organic Industries Ltd/Q1 FY27

Laxmi Organic Industries Ltd Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹171P/E: 38.3Market Cap: ₹4.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • →Specialty business shows positive momentum with key products growing; ramp-up expected in FY28 and FY29 with Dahej Phase 2 commissioning.
  • →Dahej project Phase 2 expected to complete mechanical stabilization by Q3 FY27, contributing to revenue in FY28.
  • →Essentials business revenue grew 50% YoY in Q1 FY27, with a 10% volume growth and price/product mix contributing to the rest.
  • →Volume growth for Essentials segment in Q1 FY27 was double-digit; guidance on future volume growth points to capacity absorption by FY28/FY29.
  • →Company expects to ramp up new capacities steadily, with utilization improving over the next 1-2 years.
  • →EBITDA margins for Essentials expected around mid-single-digit over the cycle; specialty margins are more variable due to batch processes.
  • →Overall, the company anticipates steady annual growth, leveraging economies of scale, new capacity, and strong customer demand.

Margin guidance

Category 3
  • →Specialty business: Positive momentum seen in Q1 FY27 with key products growing; ramp-up of new Dahej capacities expected to drive growth in FY28 and FY29.
  • →Hitachi project expected to start contributing revenue from FY28 after mechanical completion and stabilization in Q3 FY27.
  • →Incremental annualized depreciation post-capitalization of Dahej Phase 2 estimated at INR 28-30 crores annually (~INR7-7.5 crores per quarter).
  • →Debt peaked around INR 6,100 million; repayments to start next year and continue over 5 years, indicating potential debt reduction.
  • →Essentials business EBITDA expected to average mid-single-digit percentages over the cycle, with Q1 FY27 EBITDA around 11-12% signaling a positive trend.
  • →Overall, earnings and operating profits should improve with capacity ramp-up, product portfolio expansion, and better pricing dynamics despite volatile raw material costs.
  • →Management advises viewing specialty segment margins and earnings over a 2-3 year period due to batch processes and seasonality.

3 more insights locked — sign up free to unlock

Fundraise plans

No
  • →The company’s term debt has peaked at approximately INR 6,100 million as of Q1 FY27.
  • →Debt repayment is scheduled to start from next year and will continue for another 5 years.
  • →No explicit mention of any new debt or equity fundraising plans in the near term.
  • →Capex related to Dahej Phase 2 is nearing completion, with INR 125-150 crores capex planned for the full year.
  • →Post commissioning of new capacities, the focus appears to be on ramp-up and debt reduction rather than raising additional funds.
  • →Net debt-to-equity ratio stands healthy at around 0.3x, indicating manageable leverage.
  • →Overall, no current or immediate plans for new fundraising via debt or equity were disclosed during the call.

Order book

  • →The transcript does not explicitly mention the current or expected order book or pending orders by Laxmi Organic Industries Limited.
  • →However, the company highlights a "very robust pipeline" in their specialty business, indicating strong ongoing product development and potential future orders.
  • →For the Dahej Phase 2 project, the company expects mechanical completion and stabilization in Q3 FY27 with ramp-up and revenue contribution anticipated from FY28 onwards.
  • →The Specialty segment, especially diketene derivatives, is seeing positive momentum and customer demand, implying a healthy order flow.
  • →The Essentials business is described as agile and strong, with ongoing customer support during volatile market conditions, suggesting steady order inflow.
  • →Overall, while specific figures are not disclosed, the management conveys confidence in demand and ramp-up for their new capacities with an optimistic outlook on future orders.

Capex plans

Yes
  • →The Dahej project (Phase 1 capitalized; Phase 2 nearing completion) is the key ongoing capital investment.
  • →Phase 2 capitalization (around 85% of total Dahej capex) expected in Q2 FY27.
  • →Full-year capex estimate (including Dahej) is between INR 125-150 crores for FY27.
  • →Post commissioning of Dahej Phase 2, depreciation will increase by approximately INR 7-7.5 crores per quarter.
  • →Debt peaked around INR 610 crores, with repayments starting next year continuing over 5 years.
  • →Management focuses on ramping up new capacities at Dahej, with full revenue contributions expected from FY28.
  • →No other new strategic investments explicitly mentioned but ongoing robust pipeline with specialty business expansion and technology platforms like electrochemical fluorination.

How does Laxmi Organic Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Laxmi Organic Industries Ltd
Rev 2Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Laxmi Organic Industries Ltd rank in Chemicals & Petrochemicals?

Compare Laxmi Organic Industries Ltd against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Laxmi Organic Industries Ltd

Other quarters — Laxmi Organic Industries Ltd

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Laxmi Organic Industries Ltd full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Laxmi Organic Industries Ltd's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q2 FY26 earnings call analysis →
  • Q4 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fine Organic (Q3 FY26)

    Investment of approximately INR 700-750 crores for Phase 1. Key concall takeaways from Fine Organic's Q3 FY26 earnings call — and how it ranks against sector…

  • NOCIL (Q4 FY26)

    The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…

  • Indo Borax & Chemicals Ltd (Q4 FY26)

    175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF